Literature DB >> 4355270

Cellular reaction in trophoblastic tumours.

C W Elston, K D Bagshawe.   

Abstract

The presence of a mononuclear cell reaction to 41 gestational choriocarcinomata, 10 invasive moles and 13 malignant trophoblastic teratomata has been investigated. The intensity of the reaction was graded; there was a significantly better response to therapy and survival rate in those with a "severe" cellular reaction than in those with a "mild" reaction to gestational choriocarcinoma. The pathological and clinical features of invasive moles showed no relationship with the cellular reaction to the tumour. The cellular reaction to trophoblastic teratomata was generally poor but there was a marked cellular reaction to the tumour of one patient who has enjoyed a sustained remission.The relationship of cellular reaction and response to treatment with other histological and clinical features was examined. With the exception of a positive correlation between the degree of vascular invasion and response to treatment, none was found.It is suggested that an infiltrate of mononuclear cells in gestational choriocarcinoma is probably a response to the presence of tumour antigens. The infiltrate favourably affects the response to chemotherapeutic agents, suggesting that it contributes to tumour cell death and it may be interpreted as an immunological response directed at tumour rejection.

Entities:  

Mesh:

Year:  1973        PMID: 4355270      PMCID: PMC2008989          DOI: 10.1038/bjc.1973.144

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  MATERNAL IMMUNOLOGIC TOLERANCE.

Authors:  E J BREYERE
Journal:  Med Ann Dist Columbia       Date:  1964-03

2.  TROPHOBLASTIC TUMOURS. CHEMOTHERAPY AND DEVELOPMENTS.

Authors:  K D BAGSHAWE
Journal:  Br Med J       Date:  1963-11-23

3.  Transplantation non-antigenicity of the foetal placenta.

Authors:  V HASKOVA
Journal:  Nature       Date:  1962-01-20       Impact factor: 49.962

4.  Choriocarcinoma. Observations on the etiology.

Authors:  J S SCOTT
Journal:  Am J Obstet Gynecol       Date:  1962-01-15       Impact factor: 8.661

Review 5.  Immunocytes and immunoglobulins.

Authors:  R C Mellors
Journal:  Blood       Date:  1966-06       Impact factor: 22.113

6.  ABO blood-groups in trophoblastic neoplasia.

Authors:  K D Bagshawe; G Rawlins; M C Pike; S D Lawler
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

7.  Cellular reaction to choriocarcinoma.

Authors:  C W Elston
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

8.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

9.  Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

Review 10.  Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.

Authors:  D J Laurence; A M Neville
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

View more
  5 in total

1.  The histopathology of trophoblastic tumours.

Authors:  C W Elston
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

2.  Immunogenetics of trophoblastic tumours.

Authors:  S D Lawler
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

3.  Immunological aspects of trophoblastic neoplasia.

Authors:  K D Bagshawe
Journal:  Br J Cancer Suppl       Date:  1973-08

4.  Walker Prize Lecture, 1977. Choriocarcinoma: can we afford to cure cancer.

Authors:  K D Bagshawe
Journal:  Ann R Coll Surg Engl       Date:  1978-01       Impact factor: 1.891

Review 5.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.